Trademark: 97402981
Status Date
Tuesday, March 19, 2024
Filing Date
Tuesday, May 10, 2022
Published for Opposition
Tuesday, March 12, 2024
9 Clinical laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; automated fluorescent-based microscopy system comprising light-emitting diodes (LED), objective lens, digital camera charge-coupled device (CCD), motorized slide carrier, and downloadable diagnostic software for data reduction; wireless routers; gateway routers in the nature of computer control hardware; downloadable computer software for capturing, organizing, reporting, and management of medical information and data; Automated molecular diagnostic instrument for clinical laboratory use in detecting pathogens
5 Chemical, biochemical and biological preparations for medical use in cassette form, namely, for use in measuring, testing and analyzing blood and other bodily fluids; chemical reagents in cassette form for medical purposes, namely, for use in connection with diagnostic test kits for the detection of a wide variety of diseases, conditions, and disorders; diagnostic reagent test kits comprising detection and identification staining reagents, associated quality control reagents, and customized microscopy slides, for medical and clinical medical use; In vitro medical diagnostic test kits for clinical, professional, medical and consumer use consisting primarily of medical diagnostic reagents together with test equipment in the nature of a medical testing device for monitoring medical conditions, monitoring antibodies, and diagnosing viral, inflammatory and infectious diseases and diagnosing and monitoring genetic disorders for medical use
1 Diagnostic reagent test kits comprised of monoclonal antibodies, buffers, and reagents for clinical or medical laboratory, scientific or research use; diagnostic reagent test kits comprising detection and identification staining reagents, associated quality control reagents, and customized microscopy slides, for clinical laboratory use; diagnostic reagent test kits comprising detection and identification staining reagents, associated quality control reagents, and customized microscopy slides, for clinical research use
10 Devices in the nature of glass slides, cups, bags for the collection of bodily excretions and fluids from humans for medical diagnostic purposes; devices in the nature of glass slides, cups, bags and test components in the nature of medical testing devices sold as a kit for the collection, preservation and shipment of bodily excretions and fluids from humans for clinical medical diagnostic purposes; medical diagnostic apparatus comprised of an optics window, a port for a reagent test, and an illuminating device, specifically adapted for reading in vitro medical test results; medical diagnostic analyzers for measuring, testing and analyzing blood and other bodily fluids; In vitro medical diagnostic test kits for clinical, professional, medical and consumer use consisting primarily of reagents together with test equipment in the nature of a medical testing device for monitoring conditions and diagnosing disease; Automated molecular diagnostic instrument for clinical laboratory use in detecting pathogens
42 Providing online non-downloadable web-based software that allows users to access medical information and data; providing temporary use of on-line non-downloadable cloud computing software for capturing, organizing, reporting, and remote management of medical information and data
Mar 19, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 19, 2024
Published For Opposition
Feb 28, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 28, 2024
Notification Of Notice Of Publication E-Mailed
Jan 29, 2024
Approved For Pub - Principal Register
Jan 27, 2024
Teas/Email Correspondence Entered
Jan 26, 2024
Correspondence Received In Law Office
Jan 26, 2024
Teas Response To Office Action Received
Oct 25, 2023
Application Extension Granted/Receipt Provided
Oct 25, 2023
Application Extension To Response Period - Received
Jul 26, 2023
Notification Of Non-Final Action E-Mailed
Jul 26, 2023
Non-Final Action E-Mailed
Jul 26, 2023
Non-Final Action Written
Jul 24, 2023
Previous Allowance Count Withdrawn
Jun 27, 2023
Withdrawn From Pub - Og Review Query
Jun 13, 2023
Approved For Pub - Principal Register
Jun 13, 2023
Examiner's Amendment Entered
Jun 13, 2023
Notification Of Examiners Amendment E-Mailed
Jun 13, 2023
Examiners Amendment E-Mailed
Jun 13, 2023
Examiners Amendment -Written
Jun 12, 2023
Previous Allowance Count Withdrawn
May 30, 2023
Withdrawn From Pub Otqr Request
May 11, 2023
Approved For Pub - Principal Register
May 10, 2023
Teas/Email Correspondence Entered
May 10, 2023
Correspondence Received In Law Office
May 10, 2023
Teas Response To Office Action Received
Mar 6, 2023
Notification Of Non-Final Action E-Mailed
Mar 6, 2023
Non-Final Action E-Mailed
Mar 6, 2023
Non-Final Action Written
Feb 28, 2023
Assigned To Examiner
Jan 3, 2023
Teas Change Of Correspondence Received
Jan 3, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 3, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 3, 2022
Automatic Update Of Assignment Of Ownership
May 16, 2022
New Application Office Supplied Data Entered
May 13, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
